Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rentaro Oda

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Pharmacotherapy|November 20, 2023
Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended-Spectrum β-lactamase producing Enterobacterales (ESBL-E)Takaya Namiki, Yuta Yokoyama, Hideki Hashi, et al.
Biological & Pharmaceutical Bulletin|May 7, 2025
Efficacy of De-Escalation to Cefmetazole in Patients with Bacteremic Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coliTakaya Namiki, Yuta Yokoyama, Motonori Kimura, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 29, 2021
Multiple mycotic aneurysms with infective endocarditis: A case reportKentaro Mitsui, Rentaro Oda, Tetsumin Lee, et al.
Vaccine|April 3, 2026
Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUSHaruka Maeda, Nobuo Saito, Ataru Igarashi, et al.
Expert Review of Vaccines|January 30, 2024
Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)Haruka Maeda, Nobuo Saito, Ataru Igarashi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 13, 2023
Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trialSho Saito, Satoshi Kutsuna, Imamura Akifumi, et al.
Annals of Clinical Epidemiology|March 20, 2024
Development and external validation of a deep learning-based computed tomography classification system for COVID-19Yuki Kataoka, Tomohisa Baba, Tatsuyoshi Ikenoue, et al.
The New England Journal of Medicine|April 11, 2020
Compassionate Use of Remdesivir for Patients with Severe Covid-19Jonathan Grein, Norio Ohmagari, Daniel Shin, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Pharmacotherapy|November 20, 2023
Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended-Spectrum β-lactamase producing Enterobacterales (ESBL-E)Takaya Namiki, Yuta Yokoyama, Hideki Hashi, et al.
Biological & Pharmaceutical Bulletin|May 7, 2025
Efficacy of De-Escalation to Cefmetazole in Patients with Bacteremic Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coliTakaya Namiki, Yuta Yokoyama, Motonori Kimura, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 29, 2021
Multiple mycotic aneurysms with infective endocarditis: A case reportKentaro Mitsui, Rentaro Oda, Tetsumin Lee, et al.
Vaccine|April 3, 2026
Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUSHaruka Maeda, Nobuo Saito, Ataru Igarashi, et al.
Expert Review of Vaccines|January 30, 2024
Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)Haruka Maeda, Nobuo Saito, Ataru Igarashi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 13, 2023
Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trialSho Saito, Satoshi Kutsuna, Imamura Akifumi, et al.
Annals of Clinical Epidemiology|March 20, 2024
Development and external validation of a deep learning-based computed tomography classification system for COVID-19Yuki Kataoka, Tomohisa Baba, Tatsuyoshi Ikenoue, et al.
The New England Journal of Medicine|April 11, 2020
Compassionate Use of Remdesivir for Patients with Severe Covid-19Jonathan Grein, Norio Ohmagari, Daniel Shin, et al.
Pageof 2